Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
about
The association between diabetes related medical costs and glycemic control: a retrospective analysis.Incorporating Natural Products, Pharmaceutical Drugs, Self-Care and Digital/Mobile Health Technologies into Molecular-Behavioral Combination Therapies for Chronic DiseasesUtilization patterns of insulin therapy and healthcare services among Japanese insulin initiators during their first year: a descriptive analysis of administrative hospital dataHow are we doing with the treatment of essential tremor (ET)?: Persistence of patients with ET on medication: data from 528 patients in three settings.Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease.Noncompliance in the use of cardiovascular medications in the Medicare Part D populationEffects of miglitol taken just before or after breakfast on plasma glucose, serum insulin, glucagon and incretin levels after lunch in men with normal glucose tolerance, impaired fasting glucose or impaired glucose tolerance.High-risk diabetic patients in Medicare Part D programs: are they getting the recommended ACEI/ARB therapy?Importance of including early nonadherence in estimations of medication adherence.Using quantile regression to investigate racial disparities in medication non-adherence.A retrospective database analysis of insulin use patterns in insulin-naïve patients with type 2 diabetes initiating basal insulin or mixtures.Intervention strategies for improving patient adherence to follow-up in the era of mobile information technology: a systematic review and meta-analysis.Comparisons of persistence and durability among three oral antidiabetic therapies using electronic prescription-fill data: the impact of adherence requirements and stockpiling.An explanatory randomised controlled trial of a nurse-led, consultation-based intervention to support patients with adherence to taking glucose lowering medication for type 2 diabetesDrug titration patterns and HbA 1c levels in type 2 diabetes.How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus.Medication utilization patterns among type 2 diabetes patients initiating Exenatide BID or insulin glargine: a retrospective database study.Factors associated with adherence to nucleos(t)ide analogs in chronic hepatitis B patients: results from a 1-year follow-up study.Factors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetesMeasuring Persistence to Oral Hypoglycemic Agents in Type 2 Diabetic VeteransA literature review to investigate the link between psychosocial characteristics and treatment adherence in cancer patients.Delay of insulin addition to oral combination therapy despite inadequate glycemic control: delay of insulin therapy.Effects of interventions promoting monitoring of medication use and brief messaging on medication adherence for people with Type 2 diabetes: a systematic review of randomized trials.Prediction of Self-Management Behavior among Iranian Women with Type 2 Diabetes: Application of the Theory of Reasoned Action along with Self-Efficacy (ETRA).The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review.Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.Differential impact of longitudinal medication non-adherence on mortality by race/ethnicity among veterans with diabetesFactors affecting therapeutic compliance: A review from the patient's perspective.Glycemic control and diabetes-related health care costs in type 2 diabetes; retrospective analysis based on clinical and administrative databases.Medication taking and diabetes: a systematic review of the literature.Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databasesMeasuring the rate of therapeutic adherence among outpatients with T2DM in EgyptStructural role of perceived benefits and barriers to self-care in patients with diabetes.Can health promotion model constructs predict nutritional behavior among diabetic patients?New prescription medication gaps: a comprehensive measure of adherence to new prescriptions.Evaluation of adherence to morning versus evening glaucoma medication dosing regimens.Insulin adherence and persistence among Chinese patients with type 2 diabetes: a retrospective database analysis.Empirical validation of the information-motivation-behavioral skills model of diabetes medication adherence: a framework for intervention.A new approach to glucose control in type 2 diabetes: the role of kidney sodium-glucose co-transporter 2 inhibition.Does antidepressant medication use affect persistence with diabetes medicines?
P2860
Q25255574-3C2416ED-5593-4761-991D-64D61EFB77EFQ28069705-C62ED211-58B4-4637-8688-403821E2A1A8Q31036542-2D20564B-0201-45A0-B31B-DDF6D0EFCA34Q33523378-76D4D35C-B1CE-492F-8612-16F6F968F838Q33562464-E1CA19E5-FA7E-4EFB-A27F-D3DA3C1AAF08Q33567812-9E6E6263-E2F0-4BF2-8BF6-2A13F6AB24E6Q33585555-480F6939-4F40-49FB-9702-EEB21958000CQ33742516-88258BDE-8B14-47FA-AA61-815FAF27E9C8Q33852705-2250EEF5-92E6-4EEC-8EDE-1B2898DDC24FQ33924589-89C1EEE8-8EB4-4C90-8C2D-1F04D77D1569Q33966104-30423DCC-4074-4F63-BB0E-BB8B494803DFQ34011228-C9CD7169-0FDF-4C3A-8054-43CE7D19665DQ34065562-42416D78-987D-4D31-82D5-02387E02AF2BQ34223066-8BCDF23F-1DAC-465F-8403-6EACE1579146Q34322132-33EAEC3B-3826-48C1-945D-BE98E2D5C71CQ34344393-45268ADE-0941-4C2F-BC59-90161BAE94A6Q34782893-8585EF5C-E4F0-4CA9-8EB5-D88F92F47B42Q34952020-BEAC756E-39A3-4E0F-BAE4-FF3239693500Q35043805-63D29E3A-8280-4F31-964A-3E326EADBB72Q35113964-2D5A8CC8-5320-4966-8FF5-C0B072CFEC9EQ35569367-D5EA79EF-5ECA-4F8E-85CD-9008E353A39EQ35691530-8CB56D8F-CA3F-49BB-A705-6F5F11E613CAQ35809160-58F37337-EE52-47BE-B34B-42BACE421D03Q36022674-3BC44C24-2C6A-45DF-BCB4-60D62612FBB8Q36432150-152C8FBB-0D6E-43E9-BA30-9DAE4A8726B0Q36734086-2A71EA9B-2F34-4B83-8FB6-3AA9B50F0BBBQ36734095-9947BFCC-634C-4192-B780-08B4409CE4ACQ36822915-A8ECD153-77D2-4484-B8BA-CD6E3D22A887Q36857207-62902E8B-D156-4618-A3CA-3B04B76DC2EBQ37023520-4A4170DD-ED79-4052-BA21-00B04BBAE193Q37055744-C9830569-E91D-406E-8195-DF78E9F0F826Q37063292-8F57EACF-0C56-4C44-AD67-D3022DBB5AFCQ37186524-243D958C-BB0A-43ED-AEEF-83357B400539Q37222175-B1F65F19-817D-49F6-B9B1-03122725D612Q37368835-454085C0-6EF5-4717-83A4-B7C668669D86Q37577399-CAFF68C1-C558-4239-82CC-35D99DFFE801Q37650091-65F89C09-CDF4-4B38-91B4-DD3AD672FA3FQ37715533-742115D7-DEDD-43CE-8B55-636DC5D30BD9Q37890777-7A714C2F-EDC9-4755-B2AF-AE5AC8FA7890Q38085270-D7A0BBD3-065D-4DC2-A1AD-670208779A45
P2860
Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Adherence with pharmacotherapy ...... er-sponsored health insurance.
@en
Adherence with pharmacotherapy ...... er-sponsored health insurance.
@nl
type
label
Adherence with pharmacotherapy ...... er-sponsored health insurance.
@en
Adherence with pharmacotherapy ...... er-sponsored health insurance.
@nl
prefLabel
Adherence with pharmacotherapy ...... er-sponsored health insurance.
@en
Adherence with pharmacotherapy ...... er-sponsored health insurance.
@nl
P2093
P1476
Adherence with pharmacotherapy ...... er-sponsored health insurance.
@en
P2093
Alan N Unger
Michael B Lustik
Robin P Hertz
P304
P356
10.1016/J.CLINTHERA.2005.07.009
P577
2005-07-01T00:00:00Z